We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WHC:ASXWhitehaven Coal Limited Analysis

Data as of 2026-06-19 - not real-time

A$8.04

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Whitehaven Coal trades at AU$8.04, well below its DCF fair value of AU$26.47, suggesting a substantial valuation gap. Technical signals show a bullish alignment of the 20‑day, 50‑day and 200‑day moving averages, yet the MACD is bearish and volume is decreasing, indicating short‑term pressure near the identified support at AU$7.91. The RSI of 38 points to modest oversold conditions, while the stock’s beta is near zero, reflecting limited market correlation but a 30‑day volatility of over 43% adds price swing risk. Fundamentally, revenue has fallen 27.7% YoY and margins are thin, but the company maintains a healthy free cash flow of over AU$1.7 bn, a modest debt‑to‑equity of 34.2%, and a sustainable dividend yield of 0.96% with a payout ratio under 20%.
Given the pronounced undervaluation, solid cash generation, and attractive dividend, the stock presents a compelling value case, though investors must weigh the high sector and regulatory headwinds facing thermal coal, as well as the elevated short‑term volatility and bearish MACD momentum.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above support at AU$7.91
  • Bearish MACD histogram and decreasing volume
  • RSI indicating mild oversold condition

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation discount to DCF fair value
  • Sustainable dividend with low payout ratio
  • Strong free cash flow despite revenue decline

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Long‑term sector headwinds for thermal coal
  • Moderate debt levels and solid balance sheet
  • Potential for continued dividend payouts if cash flow remains robust

Key Metrics & Analysis

Financial Health

Revenue Growth-27.70%
Profit Margin12.66%
P/E Ratio10.2
ROE11.33%
ROA0.19%
Debt/Equity34.20
P/B Ratio1.1
Op. Cash FlowA$390.0M
Free Cash FlowA$1.7B
Industry P/E20.1

Technical Analysis

TrendBullish
RSI39.0
SupportA$7.91
ResistanceA$9.62
MA 20A$8.76
MA 50A$8.37
MA 200A$7.91
MACDBearish
VolumeDecreasing
Fear & Greed Index92.14

Valuation

Fair ValueA$26.47
Target PriceA$8.80
Upside/Downside9.41%
GradeUndervalued
TypeValue
Dividend Yield0.96%

Risk Assessment

Beta0.01
Volatility43.82%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.